Overview
Masahiro Hirayama practices in Miemachi, Japan. Mr. Hirayama is rated as an Experienced expert by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Cerebral Hypoxia, Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Ileostomy.
His clinical research consists of co-authoring 99 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic-Uremic Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Mr. Hirayama isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Cerebral HypoxiaMr. Hirayama isAdvanced. Learn about Cerebral Hypoxia.
- Graft Versus Host Disease (GvHD)Mr. Hirayama isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Flaccid Myelitis (AFM)Mr. Hirayama isExperienced. Learn about Acute Flaccid Myelitis (AFM).
- Acute Myeloid Leukemia (AML)Mr. Hirayama isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMr. Hirayama isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AnemiaMr. Hirayama isExperienced. Learn about Anemia.
- ArrhythmiasMr. Hirayama isExperienced. Learn about Arrhythmias.
- AsthmaMr. Hirayama isExperienced. Learn about Asthma.